Mereo BioPharma (MREO) Other Operating Expenses (2025 - 2026)
Mereo BioPharma (MREO) posted quarterly Other Operating Expenses of $2.0 million for Q1 2026, up 221.48% year-on-year from $636735.3 in Q1 2025, and up 582.33% on a QoQ basis from $300000.0 in Q3 2025.
Mereo BioPharma (MREO) Other Operating Expenses (2025 - 2026) Analysis & Trends
Mereo BioPharma (MREO) has reported Other Operating Expenses for 2 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.
- Quarterly Other Operating Expenses rose 221.48% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.3 million (up 239.29% YoY) and the FY2022 annual result came in at $951244.9, changed N/A from the prior year.
- Other Operating Expenses climbed to $2.0 million in Q1 2026 per MREO's latest filing, from $300000.0 in the prior quarter.
- Over the last five years, Other Operating Expenses for MREO reached as high as $2.0 million in Q1 2026 and fell as low as -$1.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Mereo BioPharma | 232.52 Mn | 232.52 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.05 Mn |
| Sep 30, 2025 | 300,000.00 |
| Mar 31, 2025 | -1.69 Mn |